There is a need for effective treatment options to control the increasing cases of cancer and deaths due to it. In this context, innovation in immuno-oncology (IO) drugs may prove important.
A recently published report suggests that the biggest innovation in cancer treatment in the next five years could be in immuno-oncology drugs. These drugs are based on cancer immunotherapy and have the potential to completely change the way cancer is treated.
Key findings of the report:
- New technologies: New technologies like checkpoint inhibitors, CAR-T cell therapy and cancer vaccines will play an important role in immunotherapy. The report is based on a survey of 128 pharma industry professionals and is being seen as a new direction for cancer treatment.
- Future prospects: Urte Jakimaviciute, senior director of the Healthcare Division, believes that advances in immunotherapy could completely change the way cancer is treated. More effective and personalized treatments are likely to become available in the future, which may revolutionize cancer treatment.
Importance of anti-obesity drugs:
The survey also revealed that anti-obesity drugs such as GLP-1 receptor agonists are also being considered as a key innovation area for the pharma industry. These drugs help control obesity and are emerging as a solution to the global health crisis.
Increasing cases of cancer:
Cancer has currently become a serious global health crisis. According to the World Health Organization (WHO), about 20 million new cancer cases are expected worldwide in 2022, with about 9.7 million deaths. Lung, breast and colorectal cancer are the most common causes of death.
Need for latest treatment options:
The report also states that 1 in 5 people face cancer at some point in their lives, and 1 in 9 men and 1 in 12 women die from the disease. These figures make the need for latest and effective drugs in cancer treatment even more important.
